The five-year survival rate of most stage 1b2 cervical cancer surgeries is above 90%, which should be determined by combining the pathological type and the patient’s physical condition. Stage 1b2 cervical cancer still belongs to the early stage according to TNM staging criteria. Radical surgery can be performed to remove or enlarge the tumor tissue, and according to the pathological tissue analysis report after the surgery, it can be determined whether to carry out radiotherapy, chemotherapy and other treatments, and the overall five-year survival rate can reach more than 90%, but the specific details still need to be determined by the type of pathology and the patient’s physical condition. If the cervical cancer is highly malignant, metastasis or spreading may occur in the early stage, and it is difficult to remove the cancer cells completely with surgery and post-treatment, and it is easy to recur and metastasize in the later stage, so the five-year survival rate may be lower than 90%; however, if it is a low malignant cervical cancer patient, the five-year survival rate will be even higher, and it may even reach more than 95%.